Takebe N - Search Results

1

Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.

Coyne GO, Takebe N, Chen AP. Coyne GO, et al. Among authors: takebe n. Curr Probl Cancer. 2017 May-Jun;41(3):182-193. doi: 10.1016/j.currproblcancer.2017.02.001. Epub 2017 Feb 11. Curr Probl Cancer. 2017. PMID: 28372823

2

National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.

Abrams J, Conley B, Mooney M, Zwiebel J, Chen A, Welch JJ, Takebe N, Malik S, McShane L, Korn E, Williams M, Staudt L, Doroshow J. Abrams J, et al. Among authors: takebe n. Am Soc Clin Oncol Educ Book. 2014:71-6. doi: 10.14694/EdBook_AM.2014.34.71. Am Soc Clin Oncol Educ Book. 2014. PMID: 24857062 Free article. Review.

3

Recent innovations in the USA National Cancer Institute-sponsored investigator initiated Phase I and II anticancer drug development.

Bando H, Takebe N. Bando H, et al. Among authors: takebe n. Jpn J Clin Oncol. 2015 Nov;45(11):1001-6. doi: 10.1093/jjco/hyv144. Epub 2015 Sep 29. Jpn J Clin Oncol. 2015. PMID: 26423340 Free PMC article. Review.

4

Perspectives on research activity in the USA on Cancer Precision Medicine.

Bando H, Takebe N. Bando H, et al. Among authors: takebe n. Jpn J Clin Oncol. 2016 Feb;46(2):106-10. doi: 10.1093/jjco/hyv162. Epub 2015 Nov 2. Jpn J Clin Oncol. 2016. PMID: 26531706 Free PMC article. Review.

5

Radiation-Therapeutic Agent Clinical Trials: Leveraging Advantages of a National Cancer Institute Programmatic Collaboration.

Takebe N, Ahmed MM, Vikram B, Bernhard EJ, Zwiebel J, Norman Coleman C, Kunos CA. Takebe N, et al. Semin Radiat Oncol. 2016 Oct;26(4):271-80. doi: 10.1016/j.semradonc.2016.06.005. Epub 2016 Jun 15. Semin Radiat Oncol. 2016. PMID: 27619249 Review.

6

Drug induced interstitial lung disease in oncology phase I trials.

Yonemori K, Hirakawa A, Kawachi A, Kinoshita F, Okuma H, Nishikawa T, Tamura K, Fujiwara Y, Takebe N. Yonemori K, et al. Among authors: takebe n. Cancer Sci. 2016 Dec;107(12):1830-1836. doi: 10.1111/cas.13087. Cancer Sci. 2016. PMID: 27685762 Free PMC article.

7

Pediatric oncology enters an era of precision medicine.

Seibel NL, Janeway K, Allen CE, Chi SN, Cho YJ, Glade Bender JL, Kim A, Laetsch TW, Irwin MS, Takebe N, Tricoli JV, Parsons DW. Seibel NL, et al. Among authors: takebe n. Curr Probl Cancer. 2017 May-Jun;41(3):194-200. doi: 10.1016/j.currproblcancer.2017.01.002. Epub 2017 Feb 1. Curr Probl Cancer. 2017. PMID: 28343740

8

Precision medicine in oncology.

Takebe N, Yap TA. Takebe N, et al. Curr Probl Cancer. 2017 May-Jun;41(3):163-165. doi: 10.1016/j.currproblcancer.2017.01.001. Epub 2017 Jan 24. Curr Probl Cancer. 2017. PMID: 28372822 No abstract available.

9

Considerations of developing an NGS assay for clinical applications in precision oncology: The NCI-MATCH NGS assay experience.

Lih CJ, Takebe N. Lih CJ, et al. Among authors: takebe n. Curr Probl Cancer. 2017 May-Jun;41(3):201-211. doi: 10.1016/j.currproblcancer.2017.05.003. Curr Probl Cancer. 2017. PMID: 28625332

10

Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose-finding trials.

Hirakawa A, Yonemori K, Kinoshita F, Kobayashi Y, Okuma HS, Kawachi A, Tamura K, Fujiwara Y, Rubinstein L, Harris PJ, Takebe N. Hirakawa A, et al. Among authors: takebe n. Cancer Sci. 2018 Jan;109(1):207-214. doi: 10.1111/cas.13436. Epub 2017 Dec 8. Cancer Sci. 2018. PMID: 29114963 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters